The aim of the study was to assess whether the association between abdominal aortic aneurisms (AAAs) and the angiotensin-converting enzyme (ACE) DD genotype is changed in male smokers. Material and methods. The ACE I/D polymorphism was examined by PCR in 112 subjects with AAA and in 50 control subjects. The frequency of ACE genotypes (II, ID and DD) in the patient group was assessed in subgroups divided on the basis of blood pressure, smoking and sex. Results. A significant increase in the frequency of ACE DD genotypes has been found in all AAA patients studied (odds ratio OR=2.6; range 1.3-5.6, p<0.0002) when compared to the remaining ACE genotypes (ID and II) and the control group. The respective values were higher when all 74 male smokers with AAA were assessed (OR=3.6; p<0.006). No increase in ACE DD genotype frequency was seen in all females (38) and male nonsmokers when compared to the respective control group (n=16) (OR=1.4; p<0.75). In the group of normotensive AAA patients, the proportion of ACE DD genotype in relation to the remaining ACE genotypes (ID and II) was found to be higher than in the general AAA patient population (odds ratio OR=6.14; range 2.5-14.9, p<0.0001). In 32 normotensive male smokers with AAA, the respective values were higher (OR=8.3).
Angiotensin I -converting enzyme (ACE) is a key component of the renin-angiotensin system. The insertion/deletion polymorphism in the ACE gene accounts for half of the variance noted in serum enzyme levels (1) .
In Japan no changes in the distribution of ACE I/D genotypes have been found in AAA patients (2) . In Italian population an increased frequency of the ACE DD genotype has been reported to occur mainly in normotensive patients with abdominal aortic aneurism (AAA) (3) . The authors consider this an indication that the ACE DD genotype participates in the pathogenesis of AAA in this group of patients. The pooling of normotensive and hypertensive AAA patient groups in the discussed Italian study (3) generates, however, the group which also displays the significantly increased frequency of ACE DD genotypes as compared to the authors' control group (OR=2.9; range 1.7-5.1, p<0.0002). The discrepancy between this observation and that of Hamano (2) may be explained by the different ethnic background.
The ACE gene has been associated with hypertension in men but not in women (4, 5) . The higher frequencies of the diseased vessels and stenotic lesions were noted in ACE DD patients with acute myocardial infarction or unstable angina pectoris, whereas this relation was absent in the parallel series of nonsmoking patients (6) . These observations prompted us to study the association between ACE I/D genotypes and AAA in normotensive male smokers.
MATERIAL AND METHODS
Subjects. ACE gene polymorphism was examined by polymerase chain reaction in 112 subjects with AAA and 50 control subjects. AAA normotensive patients (group I, n = 47) were compared to AAA hypertensive patients (group II, n = 65); each of these groups was compared to normotensive control subjects (group III, n = 50). The frequency of ACE genotypes II, ID and DD in the patient groups was also assessed in subgroups divided on the basis of blood pressure, smoking and sex. The control group consisted of 50 subjects without AAA and hypertension (group III), matched for age and sex. All subjects in this group were selected from a series of 220 blood donors. The patients and the subjects in control group were Caucasian inhabitants of the Poznan region.
The diagnosis of AAA was based on ultrasonography. Mean values of abdominal aorta diameter were 55.3 ±8.2 in the group I, 60.2 ±10.2 in the group II and 27.0±2.1 in the control group (III). In all patients an abdominal aortic aneurysmectomy was performed. Hypertension was diagnosed as a diastolic or systolic blood pressure higher than 80 or 140 mm Hg, respectively. The subjects treated with antihypertensive drugs were included in the group with hypertension (group II). Total serum cholesterol (TC) was determined by routine laboratory assays.
Genotyping of ACE
Genomic DNA was isolated from peripheral blood leukocytes by the phenol extraction method.
The I/D polymorphism in the sixteenth intron of the ACE gene was ascertained by the PCR (polymerase chain reaction) method using the primers introduced by Rigat et al. (7):   ACE F 5'-CTGGAGACCACTCCCATCCTT-TCT-3' and ACE R 5'-GATGTGGCCATCACAT-TCGTCAGAT-3'. Each PCR reaction contained 50 pmoles of each primer (5 ml each), 10 nmoles dNTP, 5 ml of concentrated (10x) Tris-HCl buffer pH 8.4, 1.5 mM MgCl 2 and 1.5 U of Taq polymerase (Sigma) in a final volume of 50 ml and was performed in a Perkin-Elmer thermal cycler. The thermocycling procedure consisted of denaturation at 94°C for 1 min, annealing at 58°C for 1 min, and extension at 72°C for 2.5 minutes; this was repeated for 35 cycles, followed by a final extension at 72°C for 6 minutes. The PCR products were separated by electrophoresis in a 1.5% agarose gel and visualized by ethidium bromide staining. The product of the insertion allele (ACE I) was 490 bp and that of the ACE D allele was 190 bp.
Statistical analysis
Results of continuous data (e.g. cholesterol) are presented as mean values ± SD (standard deviation). ACE allele frequencies and the prevalence of ACE genotypes were compared between groups using a Fisher exact test. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated based on a logistic regression analysis. P values less than 0.05 were considered as significant.
Results
Characteristics of the study population. Table 1 presents clinical data of the studied groups. There were no significant differences between the groups in terms of age, sex, smoking status or total cholesterol levels. Most subjects were male smokers. It was found that the age adjusted groups of the controls and the normotensive AAA patients characterized in this study displayed larger aortic diameters (on average by 10 mm) as compared to the corresponding groups from Italy (3), in spite of the younger age of the groups from Poland.
Prevalence of the ACE D allele and distribution of the ACE genotypes. Genotyping results are given in tab. 2 and 3. The values of ACE I/D allele frequencies are noted considering associations with the chosen phenotypes: hypertension, male sex and smoking. These are presented in tab. 2.
The effects of associations are analysed in detail in relation to the ACE I/D genotypes (tab. 3). A significant increase in the frequency of ACE DD genotypes in relation to the remaining ACE genotypes (ID and II) and compared to the control group has been found in the series of all AAA patients studied (odds ratio OR=2.6; range 1.3-5.6, p<0.0002). When the odds ratios were compared between the groups of 74 male smokers with AAA and 34 normotensive male smokers from the control group, the respective values were higher (OR=3.6; range 1.5-9, p<0.006). No significant differences were noted in the frequency of ACE DD genotypes between the group of "females + male nonsmokers" from the series of all AAA patients (n=38) and the control group (n=16) (OR=1.4; range 0.4-5.2, p<0.75).
In the group of normotensive AAA patients, the proportion of ACE DD genotypes in relation to the remaining ACE genotypes (ID and II) was found to be higher than in the series of all AAA patients studied (odds ratio OR=6.14; range 2.5-14.9, p<0.0001). When odds ratios were compared between the groups of 32 normotensive male smokers with AAA and the 34 normotensive male smokers from the control group, the respective values were higher (OR=8.3; range 2.7-25.1, p<0.0001). No significant differences were noted in the frequency of ACE DD genotypes between the groups of "females + male nonsmokers" from the series of normotensive AAA patients (n=15) and the control group (n=16) (OR=3.4; range 0.7-15.7, p<0.15).
DISCUSSION
The present study confirms the report by Pola et al. (3) that the ACE DD genotype is associated with AAA and the effect is significantly more pronounced in normotensive AAA patients. Our study shows that the discussed association is further increased in male smokers with AAA (tab. 2 and 3). The complex nature of interactions between the considered phenotypic traits and the ACE DD genotype is indicated by yet another reported associationthe higher values of blood pressure reported in the ACE DD males (4, 5) . This leaves the mechanism of associations between the ACE DD genotype and the discussed phenotypic traits unsettled.
The increase in the ACE DD genotype odds ratio in all AAA patients (OR=2.6, tab. 3) may be considered as a measure of increased risk of the disease associated with this genotype. This compares to the two genetic polymorphisms which have been found to be associated with AAA: the MTHFR C677T with the reported values of OR=4.3 for the MTHFR 677CT genotype (8) and the PAI1 5G allele (showing the association only in the group of familial cases of AAA) (9) .
In early studies, the ACE DD genotype has been suggested to contribute to the predisposition to atherosclerosis in subjects with normal blood pressure (10) . Healthy ACE DD subjects displayed increased pressor responsiveness when treated with angiotensin I (11). Furthermore, endothelial-dependent vasodilatation was significantly blunted in ACE DD subjects without vascular disease (12) .
More recent studies on the pharmacogenetics of ACE inhibitors (ACEi) in relation to the ACE I/D genotypes may also be relevant to the As shown by Yeung et al. (22) , the rates of aneurysm expansion in AAA patients are not influenced by the ACE I/D genotypes. Since our study can be considered as an extension of the report by Pola et al. (3), a difference should be noted between the studied groups in relation to age, clinical status and aortic diameter. The mean age of all Italian groups is on average higher by 10 years as compared to the respective Polish groups. In spite of this, the normotensive controls and AAA patients in the Italian study groups both had a aortic diameter which was smaller by about 10 mm. That means that a greater age dependent increase in aortic diameters occurred in Polish subjects at an earlier age in comparison to the Italian subjects. The slightly higher percentage of smokers in the Polish control persons (78%) as compared to the Italian group (71%) represents too small a difference to explain the discussed finding. The differences between the groups could be, however, due to differences in life styles such as diet or the intensity of smoking.
The mechanisms of increased aortic stiffness with the age and with blood pressure were shown to differ in rats (24) . The age-related changes leading to an increase in aortic diameter may differ from those due to hypertension. The hypertensive patients in the presented group have an aortic diameter larger by 15 mm as compared to controls and larger by 5 mm as compared to the normotensive AAA patients (p<0.05). In the Italian study no increase in aortic diameter was reported in the hypertensive AAA patients as compared to the normotensive AAA patients. This suggests that the Polish study group may represent more advanced stages of the disease.
In conclusion, the frequency of ACE DD genotypes in AAA subjects was enhanced in the groups characterized by normal blood pressure, male sex and cigarette smoking. The difference was compatible with the assumption that all the reported differences for AAA patients are generated in the groups of normotensive male smokers. This assumption is further supported by the finding of no increases in ACE DD genotypes in females and male nonsmokers. Comparison of the age and disease adjusted groups from the Polish and the Italian (3) populations suggests a faster increase in the aortic diameter in the Polish groups. mechanisms of the discussed association between the AAA and the ACE DD genotype in normotensive patients. ACE inhibitors (ACE I) are highly valued for their favorable effects on aortic compliance and renal flow (13) . In rat experimental models of AAA, treatment with ACEi suppressed the development of aneurysms (14) .
Depending on the clinical symptoms assessed, ACE DD patients may either fall into the group of good responders or may be nonresponders to treatment with ACE I (15). Coronary epithelium-dependent vasomotion responses to acetylcholine improved following ACE inhibition with enalaprilat in ACE DD or ID patients with atherosclerosis or endothelial dysfunction, but not in ACE II patients (16) . ACEi treatment of proteinuria is more effective in individuals with the ACE DD genotype (17). Conversely, transplant-free survival of ACE DD subjects was significantly poorer in the prospective study of patients with systolic dysfunction who were followed for 2.5 years or to the end point of either death or heart transplantation. This handicap occurred only in subjects who did not take their prescribed >-blocker therapy (18) .
In addition, cardiac morbidity and mortality in patients undergoing coronary artery bypass graft surgery were found to be significantly greater in the ACE ID or DD patients as compared to the ACE II patients (19) .
The ACE I/D genotype was found to influence not only the response to ACE I drugs, but also to diuretics. Good responders to hydrochlorothiazide are determined by the combination of the ACE I allele and the 460Trp allele of the ADD1 (=-adducin) gene (20) .
The ACE gene maps to chromosome 17q23, spans 21 kb and comprises 26 exons and 25 introns. The functionally important membrane anchoring domain of the ACE protein is coded by exon 26. In endothelium and in epithelial tissues exons 1 to 26 of the ACE gene, excluding exon 13 are transcribed, and mRNA is 4.3 kb. In testes, transcription takes place from exons 13-26 and mRNA is 3 kb. The occurrence of two alternate promoters and the homologies between exons indicate that a duplication at some stage of evolution preceeded the creation of this gene in its present shape (21) . The ACE gene is polymorphic in all studied human populations and the functional consequences of this variation are widely studied (22 
